DE60043391D1 - Verwendung von leptin mit einem vegf hemmer und/oder angiogenese hemmer zur hemmung der proliferation endothelialer zellen - Google Patents

Verwendung von leptin mit einem vegf hemmer und/oder angiogenese hemmer zur hemmung der proliferation endothelialer zellen

Info

Publication number: DE60043391D1
Authority: DE; Germany
Prior art keywords: hemmer; leptin; angiogenic; vegf; proliferation
Prior art date: 1999-09-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60043391T

Other languages

English (en)

Inventor

Menachem Rubinstein

Batya Cohen

Dalit Barkan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yeda Research and Development Co Ltd

Original Assignee

Yeda Research and Development Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-05

Filing date

2000-09-04

Publication date

2010-01-07

1999-09-05 Priority claimed from IL13173999A external-priority patent/IL131739A0/xx

2000-09-04 Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd

2010-01-07 Application granted granted Critical

2010-01-07 Publication of DE60043391D1 publication Critical patent/DE60043391D1/de

2020-09-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Zoology (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE60043391T 1999-09-05 2000-09-04 Verwendung von leptin mit einem vegf hemmer und/oder angiogenese hemmer zur hemmung der proliferation endothelialer zellen Expired - Lifetime DE60043391D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL13173999A IL131739A0 (en)	1999-09-05	1999-09-05	Use of leptin in inhibition of endothelial cell proliferation
IL13231299A IL132312A0 (en)	1999-09-05	1999-10-10	Use of leptin in inhibition of endothelial cell proliferation
PCT/IL2000/000525 WO2001018040A2 (en)	1999-09-05	2000-09-04	Use of leptin in inhibition of endothelial cell proliferation

Publications (1)

Publication Number	Publication Date
DE60043391D1 true DE60043391D1 (de)	2010-01-07

Family

ID=26323878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60043391T Expired - Lifetime DE60043391D1 (de)	1999-09-05	2000-09-04	Verwendung von leptin mit einem vegf hemmer und/oder angiogenese hemmer zur hemmung der proliferation endothelialer zellen

Country Status (19)

Country	Link
EP (1)	EP1210108B1 (de)
JP (1)	JP2003508544A (de)
KR (1)	KR100683362B1 (de)
CN (1)	CN1189479C (de)
AR (1)	AR025494A1 (de)
AT (1)	ATE449609T1 (de)
AU (1)	AU781390B2 (de)
BR (1)	BR0013778A (de)
CA (1)	CA2382941C (de)
DE (1)	DE60043391D1 (de)
EA (1)	EA005066B1 (de)
EE (1)	EE05262B1 (de)
ES (1)	ES2335569T3 (de)
HK (1)	HK1048075B (de)
IL (1)	IL132312A0 (de)
MX (1)	MXPA02002448A (de)
NO (1)	NO325989B1 (de)
UA (1)	UA74163C2 (de)
WO (1)	WO2001018040A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355237B1 (en) *	1994-09-14	2002-03-12	Progenitor, Inc.	Methods for using the obese gene and its gene product to stimulate hematopoietic development
US8633250B2 (en) *	2006-01-12	2014-01-21	Musc Foundation For Research Development	Cell repair and regeneration by suramin and related polysulfonated napthylureas
ES2474765T3 (es) *	2009-06-17	2014-07-09	National University Corporation Kumamoto University	Agente profiláctico y/o terapéutico para la dismenorrea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2260784T3 (es) *	1996-01-23	2006-11-01	Indevus Pharmaceuticals, Inc.	Metodos de utilizacion del gen obese y su producto genico para estimular el desarrolo hematopoyetico.
IT1288388B1 (it) *	1996-11-19	1998-09-22	Angeletti P Ist Richerche Bio	Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
IL120733A0 (en) *	1997-04-29	1997-08-14	Yeda Res & Dev	Leptin as an inhibitor of cell proliferation
AU4672199A (en) *	1998-05-20	1999-12-06	Yale University	Modulation of angiogenesis and wound healing

1999
- 1999-10-10 IL IL13231299A patent/IL132312A0/xx unknown
2000
- 2000-04-09 UA UA2002042717A patent/UA74163C2/uk unknown
- 2000-09-04 EA EA200200331A patent/EA005066B1/ru not_active IP Right Cessation
- 2000-09-04 CN CNB00813748XA patent/CN1189479C/zh not_active Expired - Fee Related
- 2000-09-04 MX MXPA02002448A patent/MXPA02002448A/es active IP Right Grant
- 2000-09-04 ES ES00956758T patent/ES2335569T3/es not_active Expired - Lifetime
- 2000-09-04 EP EP00956758A patent/EP1210108B1/de not_active Expired - Lifetime
- 2000-09-04 WO PCT/IL2000/000525 patent/WO2001018040A2/en not_active Ceased
- 2000-09-04 KR KR1020027002112A patent/KR100683362B1/ko not_active Expired - Fee Related
- 2000-09-04 AR ARP000104622A patent/AR025494A1/es unknown
- 2000-09-04 HK HK03100442.1A patent/HK1048075B/zh not_active IP Right Cessation
- 2000-09-04 DE DE60043391T patent/DE60043391D1/de not_active Expired - Lifetime
- 2000-09-04 JP JP2001522262A patent/JP2003508544A/ja active Pending
- 2000-09-04 BR BR0013778-2A patent/BR0013778A/pt not_active Application Discontinuation
- 2000-09-04 AT AT00956758T patent/ATE449609T1/de not_active IP Right Cessation
- 2000-09-04 AU AU68620/00A patent/AU781390B2/en not_active Ceased
- 2000-09-04 CA CA2382941A patent/CA2382941C/en not_active Expired - Fee Related
- 2000-09-04 EE EEP200200116A patent/EE05262B1/xx not_active IP Right Cessation
2002
- 2002-02-25 NO NO20020920A patent/NO325989B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2335569T3 (es)	2010-03-30
AU6862000A (en)	2001-04-10
JP2003508544A (ja)	2003-03-04
NO20020920D0 (no)	2002-02-25
BR0013778A (pt)	2002-05-14
NO20020920L (no)	2002-05-03
EE200200116A (et)	2003-04-15
EP1210108B1 (de)	2009-11-25
CN1189479C (zh)	2005-02-16
EP1210108A2 (de)	2002-06-05
WO2001018040A2 (en)	2001-03-15
HK1048075A1 (en)	2003-03-21
NO325989B1 (no)	2008-09-01
MXPA02002448A (es)	2002-07-30
EA005066B1 (ru)	2004-10-28
CA2382941C (en)	2011-08-16
ATE449609T1 (de)	2009-12-15
CN1377277A (zh)	2002-10-30
EE05262B1 (et)	2010-02-15
HK1048075B (zh)	2005-07-29
UA74163C2 (uk)	2005-11-15
WO2001018040A3 (en)	2001-06-14
KR100683362B1 (ko)	2007-02-15
AR025494A1 (es)	2002-11-27
IL132312A0 (en)	2001-03-19
KR20020040781A (ko)	2002-05-30
EA200200331A1 (ru)	2002-08-29
CA2382941A1 (en)	2001-03-15
AU781390B2 (en)	2005-05-19

Publication	Publication Date	Title
DE69927128D1 (de)	2005-10-13	Verwendung von topisch applizierbaren Gerinnungsmaterial
DE60040234D1 (de)	2008-10-23	Automatische erstellung von dokumenten mittels anordnungselement und inhaltselementen
DE60017894D1 (de)	2005-03-10	Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
EE200300485A (et)	2004-02-16	Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE50012379D1 (de)	2006-05-04	Verwendung von nanoskaligen antischuppenwirkstoffen
DE60000958D1 (de)	2003-01-23	Epoxidharzzusammensetzung und ihre Verwendung
DE69813211D1 (de)	2003-05-15	Fingerabdrucksensor mit filterung und energiesparende eigenschaften und zugehörigen verfahren
PT1204663E (pt)	2004-02-27	Novos compostos espiro com actividade antagonista do neuropeptido y
DE59407397D1 (de)	1999-01-14	Verwendung von polymeren mit isolierten chromophoren als elektrolumineszenzmaterialien
DE60027927D1 (de)	2006-06-14	Harzstruktur und ihre verwendung
DE59903382D1 (de)	2002-12-19	Elektrolysezelle und deren Verwendung
DE69829955D1 (de)	2005-06-02	Salze von perfluorierten sulfonen und ihre verwendung als ionisch leitfähige materialien
DE59702603D1 (de)	2000-12-14	Teilkonjugierte polymere mit spirozentren und ihre verwendung als elektrolumineszenzmaterialien
DE19782175T1 (de)	1999-10-28	Anodisierender Elektrolyt und seine Verwendung
DE69603734D1 (de)	1999-09-16	Blockcopolymere von Polyolefinen mit Polyurethanen, Copolyestern oder Copolyamiden und ihre Verwendung
DE50006656D1 (de)	2004-07-08	Messeinrichtung zur Messung von Inhaltsstoffen in und/oder Eigenschaften von Erntegut
DE69827239D1 (de)	2004-12-02	Ionische perfluorvinylverbindungen und ihre verwendung in leitenden materialien
ATA57997A (de)	1998-06-15	Acryl-copolymere und polymerzusammensetzungen sowie deren verwendung als additive oder beimischungen zur verbesserung der eigenschaften von dispersionen und baustoffen
DE50005265D1 (de)	2004-03-18	Nadellager und pumpeneinheit mit einem nadellager
DE69433319D1 (de)	2003-12-18	Vernetzbare Copolyether und ihre Verwendung als polymerische Elektrolyten
DE59507232D1 (de)	1999-12-23	Konjugierte Polymere mit Ansateilstrukturen und ihre Verwendung als Elektrolumineszenzmaterialien
DE60317639D1 (de)	2008-01-03	Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
DE50003729D1 (de)	2003-10-23	Verwendung von emulsionen als imprägnier- und avivagemittel
ATE337845T1 (de)	2006-09-15	Verwendung von polymerisaten als filterhilfs- und/oder stabilisierungsmittel
DE69913923D1 (de)	2004-02-05	Drehkran und seiner Verwendung

Legal Events

Date	Code	Title	Description
2010-12-16	8364	No opposition during term of opposition